Clinical Trials Logo

Endophthalmitis clinical trials

View clinical trials related to Endophthalmitis.

Filter by:

NCT ID: NCT03958292 Completed - Clinical trials for Endophthalmitis Following Cataract Surgery

Conjunctival Flora Before Cataract Surgery: a Microbiological Evaluation

Start date: January 8, 2018
Phase: N/A
Study type: Interventional

The purpose of the present study is to elucidate the qualitative and quantitative variation of ocular flora after treatment with eyedrops containing 0.6% povidone-iodine in the eye of patients undergoing routine cataract surgery.

NCT ID: NCT03812640 Recruiting - Endophthalmitis Clinical Trials

Nylon Verus Polyglactin Corneal Suture in Pediatric Cataract Surgery

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Pediatric cataract surgery requires the suturing of the corneal incision in order to maintain the integrity of the eyeball and to help avoid the trauma often caused by scratching in the postoperative period of pediatric surgeries. Traditionally, this suturing is performed using 10-0 nylon material. Because this material is non-absorbable, it must be removed under sedation in cases of complications such as suture loosening, late suture lysis, accumulation of secretion on the suture, corneal neovascularization, and corneal ulceration. The objetive of this study is to compare the rate of postoperative complications and the need for suture removal after pediatric cataract surgery in cases in which nylon (non-absorbable) sutures are used versus cases in which polyglactin (absorbable) sutures are used. This is a controlled, randomized, prospective, single-center study performed on patients undergoing pediatric cataract surgery at the Clinical Hospital of the University of Campinas (UNICAMP). The volunteers for whom cataract extraction surgery has been indicated and who have signed the ICF (or whose ICF has been signed by a parent or guardian) will undergo cataract surgery and the cornea will be sutured using a polyglactin 910 suture (Vicryl® 10-0). In the control group (Group B), the cornea will be sutured using nylon 10-0 sutures (the current routine procedure). All patients will be monitored for six months and will receive complete ophthalmological evaluations in order to determine whether they experience any suture-related complications and whether sutures must be removed under sedation. A lower incidence of complications and a less frequent need for suture removal under sedation are expected in the group receiving Vicryl® sutures.

NCT ID: NCT03677700 Not yet recruiting - Inflammation Eye Clinical Trials

Evaluation of Inflammation of the Anterior Segment by Laser Flashmeter in Patients Having Undergone Surgery of the Posterior Segment (Vitrectomy or Preindentation) During the First Postoperative Year. (FLAVIC)

FLAVIC
Start date: September 2018
Phase:
Study type: Observational

Observational study, monocentric, prospective, descriptive and comparative (eye operated vs fellow eye).

NCT ID: NCT03635268 Completed - Clinical trials for Intravitreal Injection

Endophthalmitis After Intravitreal Injection of Antiangiogenic Agents or Corticosteroids, a Cohort Study of the French Population of Patients Who Received Injections Over 9 Years

ENIVAC
Start date: January 1, 2016
Phase:
Study type: Observational

Intravitreal injections (IVI) of antiangiogenic agents (AA) have revolutionized the management of age-related macular degeneration (AMD) and diabetic macular edema (DME) in particular. Approximately 600,000 AA IVIs are performed each year in France. Corticosteroid IVIs are an alternative in the treatment of macular edema when it is diabetic or related to venous occlusion, but also due to inflammation. Endophthalmitis is one of the most feared complications after IVI because of its poor prognosis, despite its low incidence (values found in the literature between 0.01% and 0.08%). IVI practices have evolved over the years based on the recommendations of specialized organizations, with the current recommendation not to use antibiotic prophylaxis. The purpose of this study is to study the effect of intravitreal injections of anti-angiogenic agents and corticosteroids on the occurrence of endophthalmitis within 28 days following an injection.

NCT ID: NCT03634852 Completed - Clinical trials for Endophthalmitis Postoperative

A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery

Start date: October 1, 2016
Phase: Phase 4
Study type: Interventional

Post cataract surgery bacterial endophthalmitis is a rare but the most devastating complication with a poor visual outcome. The preferred pattern of chemoprophylaxis varied world widely. The use of preoperative povidone iodine is universal. Most European surgeons prefer the use of Intracameral (IC) antibiotics whereas topical fluoroquinolone that prescribed perioperatively is the most common pattern in the United state(US). The current study aimed to evaluate the effectivity and safety of a combination of diluted IC Moxifloxacin and subconjunctival (SC) Triamcinolone acetonide as prophylaxis of bacterial endophthalmitis and postoperative inflammation in five hundred phacoemulsification surgeries and compare its results with the same number of patients treated by topical Moxifloxacin hydrochloride and Dexamethasone eye drops when given four times a day for 1month postoperatively.

NCT ID: NCT03420820 Not yet recruiting - Endophthalmitis Clinical Trials

Concentrating on Antisepsis: 5% vs. 10% Povidone-Iodine Prior to Intravitreal Injection

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

This is a randomized controlled single blind prospective study evaluating the efficacy of ocular surface sterilization between three different povidone-iodine preparation techniques prior to intravitreal injection. The primary end point is significant different between median colony-forming units pre- and post-sterilization and injection.

NCT ID: NCT03363295 Completed - Cataract Clinical Trials

Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis

Start date: July 1, 2017
Phase: Phase 4
Study type: Interventional

The objective of this study is to evaluate the macular and choroidal thickness of patients submitted to intracameral moxifloxacin during the phacoemulsification surgery for endophthalmitis prophylaxis. The investigators propose a randomized clinical trial double-blind. The patients will be divided into two groups: one will receive intracameral moxifloxacin injection during phacoemulsification surgery and the other won't. Both Spectral Domain - Optical Coherence Tomography (SD-OCT) and Enhanced Depth Imaging - Optical Coherence Tomography (EDI-OCT) will be performed for each patient pre-operatively and on the 30th and 60th postoperative days. After collecting, the data will be compared to evaluate if there was any difference in the macular thickness and choroidal thickness between the two groups.

NCT ID: NCT03244072 Not yet recruiting - Endophthalmitis Clinical Trials

Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery

Start date: June 1, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

Intracameral injection of 0.1% moxifloxacin solution after cataract surgery to prevent endophthalmitis

NCT ID: NCT02850653 Recruiting - Clinical trials for Acute Endophthalmitis Post-operative

Targeted PCR and Acute Endophthalmitis

Targeted PCR
Start date: November 2007
Phase: N/A
Study type: Interventional

Endophthalmitis is a serious eye infection of exogenous origin (post-operational, post-traumatic) or endogenous origin (metastatic). This is a diagnostic and therapeutic emergency. Each patient suffering from endophthalmitis must have immediately an ocular sampling, an intra ocular injection of antibiotics and a systemic antibiotic cover. The etiological treatment will be adapted according to the infectious agent.

NCT ID: NCT02818062 Completed - Endophthalmitis Clinical Trials

Severe Intraocular Infection

Start date: January 2008
Phase: N/A
Study type: Observational

The host-immune reaction to infection is essential for the comprehension of the disease and the development of new therapies. The aim of the study is to describe intraocular cytokines network in aqueous humor using multiplex immunoassay, during severe intraocular infection.